Cargando…

Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome

OBJECTIVE: To evaluate the safety of an aerosolised surfactant, SF-RI 1, administered via nasal continuous positive airway pressure (nCPAP) and a prototype breath synchronisation device (AeroFact), to preterm infants with respiratory distress syndrome (RDS). DESIGN: Multicentre, open-label, dose-esc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jardine, Luke, Lui, Kei, Liley, Helen G, Schindler, Timothy, Fink, James, Asselin, Jeanette, Durand, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685619/ https://www.ncbi.nlm.nih.gov/pubmed/34112722 http://dx.doi.org/10.1136/archdischild-2021-321645

Ejemplares similares

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Early Surfactant Therapy for Respiratory Distress Syndrome in Very Preterm Infants
por: Cucerea, Manuela, et al.
Publicado: (2023)

Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future
por: Jeon, Ga Won
Publicado: (2019)

Practical considerations when administering surfactants to preterm infants with respiratory distress syndrome
por: Jo, Heui Seung
Publicado: (2019)

Profound Effect of Pulmonary Surfactant on the Treatment of Preterm Infants with Respiratory Distress Syndrome
por: Liu, Lin, et al.
Publicado: (2022)

Surfactant replacement therapy for respiratory distress syndrome in preterm infants: United Kingdom national consensus
por: Banerjee, Sujoy, et al.
Publicado: (2019)

Alternative Methods of Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome: State of the Art
por: Erdeve, Ömer, et al.
Publicado: (2021)

Effects of bovine lipid extract surfactant administration in preterm infants treated for respiratory distress syndrome
por: Stockley, Elizabeth, et al.
Publicado: (2018)

Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS
por: Ramanathan, R
Publicado: (2006)

Effect of surfactant dose on outcomes in preterm infants with respiratory distress syndrome: the OPTI-SURF study protocol
por: Goss, Kevin Colin William, et al.
Publicado: (2020)

Efficacy of Surfactant-TA, Calfactant and Poractant Alfa for Preterm Infants with Respiratory Distress Syndrome: A Retrospective Study
por: Jeon, Ga Won, et al.
Publicado: (2015)

Single Nucleotide Polymorphisms Interactions of the Surfactant Protein Genes Associated With Respiratory Distress Syndrome Susceptibility in Preterm Infants
por: Amatya, Shaili, et al.
Publicado: (2021)

The Influence of the Technique of Surfactant Administration (LISA vs INSURE) on the Outcomes of Respiratory Distress Syndrome Treatment in Preterm Infants
por: Kaniewska, Urszula, et al.
Publicado: (2019)

Comparative efficacy of pulmonary surfactant in respiratory distress syndrome in preterm infants: a Bayesian network meta-analysis
por: Qiu, Caihong, et al.
Publicado: (2020)

A multicentre neonatal interventional randomised controlled trial of nebulized surfactant for preterm infants with respiratory distress: Neo-INSPIRe trial protocol
por: Lategan, Ilse, et al.
Publicado: (2023)

Comparison of minimally invasive surfactant therapy with intubation surfactant administration and extubation for treating preterm infants with respiratory distress syndrome: a randomized clinical trial
por: Sabzehei, Mohammad Kazem, et al.
Publicado: (2021)

Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and outcome
por: Mohammadizadeh, Majid, et al.
Publicado: (2015)

Corrigendum: Single nucleotide polymorphisms interactions of the surfactant protein genes associated with respiratory distress syndrome susceptibility in preterm infants
por: Amatya, Shaili, et al.
Publicado: (2022)

Aerosolised surfactant generated by a novel noninvasive apparatus reduced acute lung injury in rats
por: Sun, Yu, et al.
Publicado: (2009)

FiO(2) Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome
por: Kruczek, Piotr, et al.
Publicado: (2021)

Early Immunomodulatory Effects of Different Natural Surfactant Preparations in Preterms With Respiratory Distress
por: Yalaz, Mehmet, et al.
Publicado: (2022)

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future
por: Amigoni, Angela, et al.
Publicado: (2017)

Hypertriglyceridaemia in extremely preterm infants receiving parenteral lipid emulsions
por: Sinclair, Ruth, et al.
Publicado: (2018)

Assessment of hemodynamic changes in preterm infants with respiratory distress syndrome
por: Özdemir, Senem Alkan, et al.
Publicado: (2017)

Analysis of the cost-effectiveness of surfactant treatment (Curosurf®) in respiratory distress syndrome therapy in preterm infants: early treatment compared to late treatment
por: Dani, Carlo, et al.
Publicado: (2014)

Bronchoscopic interventions with surfactant and recombinant human deoxyribonuclease for acute respiratory distress syndrome–type respiratory syncytial virus–pneumonia in moderately preterm infants: Case series
por: Krause, Martin F, et al.
Publicado: (2014)

Surfactant proteins gene variants in premature newborn infants with severe respiratory distress syndrome
por: Somaschini, Marco, et al.
Publicado: (2017)

Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants
por: Koh, Ji Won, et al.
Publicado: (2018)

Aerosolisation in endonasal endoscopic pituitary surgery
por: Dhillon, Rana S., et al.
Publicado: (2021)

Prevention of aerosolisation during a tracheostomy
por: Wagh, Harshal D
Publicado: (2021)

Surfactant treatment before first breath for respiratory distress syndrome in preterm lambs: comparison of a peptide-containing synthetic lung surfactant with porcine-derived surfactant
por: van Zyl, Johann M, et al.
Publicado: (2013)

Pilot observational study on haemodynamic changes after surfactant administration in preterm newborns with respiratory distress syndrome
por: Vitali, Francesca, et al.
Publicado: (2014)

Surfactant Protein A and B Gene Polymorphisms and Risk of Respiratory Distress Syndrome in Late-Preterm Neonates
por: Tsitoura, Maria-Eleni I., et al.
Publicado: (2016)

The Common Haplotype GATGACA in Surfactant-Protein B Gene Is Protective for Respiratory Distress Syndrome in Preterm Neonates
por: Mikolajcikova, Silvia, et al.
Publicado: (2022)

Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China
por: Xu, Chun-cai, et al.
Publicado: (2022)

Lung ultrasonography of pulmonary complications in preterm infants with respiratory distress syndrome
por: Lovrenski, Jovan
Publicado: (2012)

Glucocorticoids, sodium transport mediators, and respiratory distress syndrome in preterm infants
por: Süvari, Liina, et al.
Publicado: (2020)

Association between Thyroid Function and Respiratory Distress Syndrome in Preterm Infants
por: Kim, Yonghyuk, et al.
Publicado: (2022)

Feasibility of ultrasound in the diagnosis of neonatal respiratory distress syndrome in preterm infants
por: Zheng, Lei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r89a5k7rv7jecc1cbupev4foe6